prednisolone has been researched along with Epidermolysis Bullosa Junctionalis, Disentis Type in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez, A | 1 |
| Almaani, N | 1 |
| Stefanato, CM | 1 |
| BhogaL, B | 1 |
| Groves, RW | 1 |
| Mellerio, JE | 1 |
| McGrath, JA | 1 |
1 other study available for prednisolone and Epidermolysis Bullosa Junctionalis, Disentis Type
| Article | Year |
|---|---|
Bullous pemphigoid in a patient with suspected non-Herlitz junctional epidermolysis bullosa.
Topics: Autoantigens; Blister; Brain Neoplasms; Collagen Type XVII; Dental Enamel Hypoplasia; Eosinophils; E | 2010 |